Activist Rejects Settlement Offer Ahead Of Vivus Proxy Vote
Tensions between drugmaker Vivus Inc. and its biggest shareholder remained high Wednesday when the company said activist investor First Manhattan Co. spurned a settlement offer that would have given both groups...To view the full article, register now.
Already a subscriber? Click here to view full article